Related Experiment Video

Updated: Aug 26, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD

Jürgen Andrich1, Carsten Saft, Anneliese Arz

  • 1Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.

Movement Disorders : Official Journal of the Movement Disorder Society
|February 24, 2004
PubMed

Insights

Elevated total homocysteine (t-Hcys) levels are found in treated Huntington

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Huntington disease (HD) is a neurodegenerative disorder.
  • The protein Huntingtin plays a role in homocysteine metabolism.
  • Elevated homocysteine levels are implicated in neurological conditions.

Purpose of the Study:

  • To investigate the association between total homocysteine (t-Hcys) levels and Huntington disease (HD).
  • To explore the potential role of homocysteine in HD-related neurodegeneration.

Main Methods:

  • Comparison of plasma t-Hcys levels in treated HD patients, untreated HD subjects, and control groups.
  • Analysis of the interaction between Huntingtin protein and cystathionine beta-synthase.

Main Results:

  • Treated HD patients exhibited significantly higher plasma t-Hcys levels than controls and untreated HD subjects.
  • The Huntingtin protein is known to interact with cystathionine beta-synthase, an enzyme crucial for homocysteine metabolism.

Conclusions:

  • Increased t-Hcys levels in treated HD patients suggest a potential link between homocysteine and disease progression.
  • Homocysteine may contribute to neurodegeneration in Huntington disease.

More Related Videos

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice08:27

Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice

Published on: March 11, 2020

In Vivo Quantification of Protein Turnover in Aging C. Elegans using Photoconvertible Dendra209:45

In Vivo Quantification of Protein Turnover in Aging C. Elegans using Photoconvertible Dendra2

Published on: June 13, 2020

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...